Genomma Lab Internacional SAB de CV (FRA:GEKA)
€ 1.18 0.01 (0.85%) Market Cap: 1.18 Bil Enterprise Value: 1.40 Bil PE Ratio: 16.50 PB Ratio: 2.40 GF Score: 70/100

Q1 2022 Genomma Lab Internacional SAB de CV Earnings Call Transcript

Apr 28, 2022 / 03:00PM GMT
Release Date Price: €1.01 (-1.94%)
Operator

Good morning, ladies and gentlemen. Thank you for standing by. Welcome to the Genomma Lab First Quarter 2022 Results Conference Call.

(Operator Instructions) A replay will also be available shortly after the conclusion of the call. I'll now turn the call over to Barbara Cano of the InspIR Group. Please go ahead.

Barbara Cano;InspIR Group

Thank you, and Good morning. We'll begin today's discussion with remarks from Jorge Luis Brake, Genomma Lab's Chief Executive Officer; followed by Antonio Zamora, Chief Financial Officer. Our call will include projections and other forward-looking statements, and it's important to note that actual results could differ materially from those projected. Genomma undertakes no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or other factors. Investors are urged to carefully review various disclosures made by the company, including the risk and other information disclosed within the company's filings with the Mexican Stock Exchange. With that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot